BOOST Thyroid raises €320K in seed funding for a digital solution to autoimmune diseases

Investors from the US and Scandinavia join the German Federal Ministry of Education and Research to fund the Berlin-based healthtech startup BOOST Thyroid, which aims to improve the lives of over 200 million people impacted by Hashimoto’s disease and other thyroid conditions.

Berlin, Germany — 09 August, 2018 — BOOST Thyroid today announced the closing of a seed funding round of €320,000 from several prominent investors, including Futuristic.VC, Wave Ventures, Sophia Bendz, Hampus Jakobsson, Simon Josefsson, and Elizabeth Carroll Dunn. The amount also includes a grant from the German Federal Ministry of Education and Research, which is awarded to companies that solve a true need in the health sector and connect basic science to business opportunities.

BOOST Thyroid, which currently offers a free iOS app, was founded in 2016 by Swedish-Croatian scientist, health advocate and Hashimoto’s patient Dr. Vedrana Högqvist Tabor and her partner, the Swedish-German scientist and engineer Dr. Mikael Högqvist Tabor. Their goal is to build a solution to help the millions of people worldwide diagnosed with Hashimoto’s. Since its founding, BOOST Thyroid has won the European Commission’s Seal of Excellence and Horizon 2020 funding, participated in Fast Track Malmö Accelerator and won the Impact Maker-south Venture Cup.

“The sustained growth we’ve seen since launching the BOOST Thyroid app in 2017 shows the demand and market need for a digital thyroid solution,” said BOOST Thyroid founder and CEO Dr. Vedrana Högqvist Tabor. “Now we can drastically evolve our product to the next level of technology, increase global awareness of thyroid conditions, and bring our solution to more people.”

The company offers a unique and innovative solution that empowers people living with thyroid autoimmune conditions to obtain scientifically vetted information, as well as providing them with tools to track medication and improve conversations with medical practitioners.

“BOOST Thyroid’s mission and vision of health for people with autoimmune diseases is inspiring. They are tackling a growing market of chronic conditions that was left untouched for too long” says Christian Jantzen, founding partner at Futuristic.VC “The founding team has a great combination of research, tech and product experience, and we look forward to together build BOOST Thyroid into the best solution for managing chronic autoimmune conditions.”

Drs Högqvist Tabor combine science, technology and the patient perspective. They seek to empower people around the globe in their daily life and in conversations with their doctors, so they can better understand their health patterns and adhere to healthier lifestyle.

“Vedrana and Mikael approach solving autoimmune conditions with a strong science background combined with technical expertise,” says Sophia Bendz a Executive in Residence at Atomico. “I am excited to be a part of this journey and bring better health prospects to people around the globe.”

This investment will be used to build out the engineering team, grow the community and user base, and expand the product.

About BOOST Thyroid

BOOST Thyroid is an AI-based app that helps people diagnosed with autoimmune diseases preventively manage their health, avoid health complications, and ensure healthier aging. Founded by Dr. Vedrana Högqvist Tabor, who has the autoimmune condition Hashimoto’s, BOOST is based in Berlin, Germany and is sponsored by the EU Horizon 2020 programme PERMIDES and the Fast Track Malmö accelerator. BOOST collaborates with University of Oxford and Royal Institute of Technology in Stockholm. For more information visit https://www.boostthyroid.com/.